Tapewire

Nasdaq · USD

ARDX

ARDELYX, INC.

Export transactions ↓
Tapewire entity
4972
SEC CIK
0001437402
Parsed reports
540

Last 12 months

Inside the activity.

1 purchase rows · 78 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 202500
Jan 202601
Feb 2026125
Mar 202601
Apr 202601
May 2026020
Jun 202602
Jul 202601
Aug 2026021
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 29, 2024 Filed May 1, 2024 23:59 UTC
RAAB MICHAELDirector · President & CEO
Exercise / conversionCommon Stock 30,000 $0.99 $29,700.00
Disclosure

SEC source: 0001610717-24-000228 · form4.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,340,933

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 20:20 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 7,500 $7.06 $52,923.75
Disclosure

SEC source: 0001610717-24-000211 · form4.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,310,933

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

F2 · price: This transaction was executed in multiple trades in prices ranging from $7.015 to $7.09, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:05 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 1,518 $7.31 $11,096.58
Disclosure

SEC source: 0001610717-24-000199 · form4.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,318,433

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 22:13 UTC
Kelliher MikeSee Remarks
GrantStock Option (Right to Buy) · Derivative 205,000 $0.00 Strike: $7.70 $0.00
Disclosure

SEC source: 0001610717-24-000188 · form4.xml · derivative · entry 2

Kelliher Mike · CIK 0001987188 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,000

Underlying: Common Stock · 205,000 shares

Expires 2034-03-25

F2 · derivative.exercise_date: Twenty Five Percent (25%) of the shares subject to the option vest on March 25, 2025 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 22:13 UTC
Kelliher MikeSee Remarks
GrantCommon Stock 160,000 $0.00 $0.00
Disclosure

SEC source: 0001610717-24-000188 · form4.xml · nonDerivative · entry 1

Kelliher Mike · CIK 0001987188 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:42 UTC SaleCommon Stock 86,000 $7.73 $664,977.80
Disclosure

SEC source: 0001610717-24-000182 · form4.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 312,993

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 20, 2023.

F2 · price: This transaction was executed in multiple trades in prices ranging from $7.65 to $7.92, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
March 15, 2024 Filed Mar 22, 2024 18:18 UTC
Blanks RobertSee Remarks
GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001610717-24-000183 · form4.xml · nonDerivative · entry 1

Blanks Robert · CIK 0001815433 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 367,186

Read SEC document
February 26, 2024 Filed Feb 28, 2024 23:57 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 5,183 $9.20 $47,683.60
Disclosure

SEC source: 0001610717-24-000103 · form4.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 175,936

F1 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 16:56 UTC
Rodriguez SusanChief Commercial Officer
SaleCommon Stock 6,928 $8.75 $60,594.37
Disclosure

SEC source: 0001610717-24-000082 · form4.xml · nonDerivative · entry 1

Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 452,795

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:56 UTC
Williams Laura AChief Medical Officer
SaleCommon Stock 4,803 $8.75 $42,008.48
Disclosure

SEC source: 0001610717-24-000080 · form4.xml · nonDerivative · entry 1

Williams Laura A · CIK 0001869194 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,138

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 16:58 UTC
Blanks RobertSee Remarks
SaleCommon Stock 5,017 $8.75 $43,880.19
Disclosure

SEC source: 0001610717-24-000084 · form4.xml · nonDerivative · entry 1

Blanks Robert · CIK 0001815433 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,186

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 17:01 UTC
Renz Justin AChief Financial Officer
SaleCommon Stock 5,341 $8.75 $46,713.99
Disclosure

SEC source: 0001610717-24-000087 · form4.xml · nonDerivative · entry 1

Renz Justin A · CIK 0001466562 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 304,835

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 23:30 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 2,294 $8.75 $20,064.01
Disclosure

SEC source: 0001610717-24-000089 · form4.xml · nonDerivative · entry 2

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 181,119

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 23:30 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 5,017 $8.75 $43,880.19
Disclosure

SEC source: 0001610717-24-000089 · form4.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 378,985

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:58 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 22,917 $8.75 $200,438.96
Disclosure

SEC source: 0001610717-24-000085 · form4.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,319,951

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:57 UTC SaleCommon Stock 4,432 $8.75 $38,763.60
Disclosure

SEC source: 0001610717-24-000083 · form4.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 398,993

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:56 UTC SaleCommon Stock 2,352 $8.75 $20,571.30
Disclosure

SEC source: 0001610717-24-000081 · form4.xml · nonDerivative · entry 1

Felsch Robert Ora · CIK 0001917819 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,834

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
February 08, 2024 Filed Feb 9, 2024 21:14 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 15,344 $9.18 $140,845.64
Disclosure

SEC source: 0001610717-24-000050 · form4.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 384,002

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.

F2 · price: This transaction was executed in multiple trades in prices ranging from $8.97 to $9.49, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 16:37 UTC
Rodriguez SusanChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 145,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001628280-24-001686 · wk-form4_1705613823.xml · derivative · entry 2

Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,000

Underlying: Common Stock · 145,000 shares

Expires 2034-01-16

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 16:37 UTC
Rodriguez SusanChief Commercial Officer
GrantCommon Stock 112,750 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-001686 · wk-form4_1705613823.xml · nonDerivative · entry 1

Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 459,723

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:39 UTC
Williams Laura AChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 152,127 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001628280-24-001692 · wk-form4_1705613951.xml · derivative · entry 2

Williams Laura A · CIK 0001869194 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,127

Underlying: Common Stock · 152,127 shares

Expires 2034-01-16

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:39 UTC
Williams Laura AChief Medical Officer
GrantCommon Stock 118,750 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-001692 · wk-form4_1705613951.xml · nonDerivative · entry 1

Williams Laura A · CIK 0001869194 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 384,941

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 16:31 UTC
Blanks RobertSee Remarks
GrantStock Option (Right to Buy) · Derivative 145,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001628280-24-001676 · wk-form4_1705613501.xml · derivative · entry 2

Blanks Robert · CIK 0001815433 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,000

Underlying: Common Stock · 145,000 shares

Expires 2034-01-16

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 16:31 UTC
Blanks RobertSee Remarks
GrantCommon Stock 112,750 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-001676 · wk-form4_1705613501.xml · nonDerivative · entry 1

Blanks Robert · CIK 0001815433 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 373,203

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 16:36 UTC
Renz Justin AChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 164,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001628280-24-001684 · wk-form4_1705613767.xml · derivative · entry 2

Renz Justin A · CIK 0001466562 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,000

Underlying: Common Stock · 164,000 shares

Expires 2034-01-16

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 16:36 UTC
Renz Justin AChief Financial Officer
GrantCommon Stock 127,750 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-001684 · wk-form4_1705613767.xml · nonDerivative · entry 1

Renz Justin A · CIK 0001466562 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 310,176

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:38 UTC
Rosenbaum David P.Chief Development Officer
GrantStock Option (Right to Buy) · Derivative 99,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001628280-24-001689 · wk-form4_1705613880.xml · derivative · entry 5

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 99,000

Underlying: Common Stock · 99,000 shares

Expires 2034-01-16

F4 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F2 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:38 UTC
Rosenbaum David P.Chief Development Officer
GrantStock Option (Right to Buy) · Derivative 145,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001628280-24-001689 · wk-form4_1705613880.xml · derivative · entry 4

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,000

Underlying: Common Stock · 145,000 shares

Expires 2034-01-16

F4 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:38 UTC
Rosenbaum David P.Chief Development Officer
GrantCommon Stock 70,120 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-001689 · wk-form4_1705613880.xml · nonDerivative · entry 2

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 183,413

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

F2 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:38 UTC
Rosenbaum David P.Chief Development Officer
GrantCommon Stock 112,750 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-001689 · wk-form4_1705613880.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 399,346

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:35 UTC
RAAB MICHAELDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 605,904 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001628280-24-001682 · wk-form4_1705613694.xml · derivative · entry 4

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 605,904

Underlying: Common Stock · 605,904 shares

Expires 2034-01-16

F4 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:35 UTC
RAAB MICHAELDirector · President & CEO
GrantCommon Stock 475,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-001682 · wk-form4_1705613694.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,342,868

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:34 UTC GrantStock Option (Right to Buy) · Derivative 164,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001628280-24-001680 · wk-form4_1705613639.xml · derivative · entry 2

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,000

Underlying: Common Stock · 164,000 shares

Expires 2034-01-16

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:34 UTC GrantCommon Stock 127,750 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-001680 · wk-form4_1705613639.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 403,425

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:32 UTC GrantStock Option (Right to Buy) · Derivative 99,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001628280-24-001678 · wk-form4_1705613557.xml · derivative · entry 2

Felsch Robert Ora · CIK 0001917819 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,000

Underlying: Common Stock · 99,000 shares

Expires 2034-01-16

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:32 UTC GrantCommon Stock 70,120 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-001678 · wk-form4_1705613557.xml · nonDerivative · entry 1

Felsch Robert Ora · CIK 0001917819 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,186

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 22:36 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 30,000 $6.64 $199,200.00
Disclosure

SEC source: 0001628280-24-001059 · wk-form4_1704926150.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 286,596

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.

F2 · price: This transaction was executed in multiple trades in prices ranging from $6.46 to $7.00, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
December 26, 2023 Filed Dec 28, 2023 17:44 UTC
Renz Justin AChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 75,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001628280-23-042828 · wk-form4_1703803478.xml · derivative · entry 3

Renz Justin A · CIK 0001466562 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,000

Underlying: Common Stock · 75,000 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2023.

F3 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
December 26, 2023 Filed Dec 28, 2023 17:44 UTC
Renz Justin AChief Financial Officer
SaleCommon Stock 225,000 $6.36 $1,430,122.50
Disclosure

SEC source: 0001628280-23-042828 · wk-form4_1703803478.xml · nonDerivative · entry 2

Renz Justin A · CIK 0001466562 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 182,426

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2023.

F2 · price: This transaction was executed in multiple trades in prices ranging from $6.28 to $6.45, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
December 26, 2023 Filed Dec 28, 2023 17:44 UTC
Renz Justin AChief Financial Officer
Exercise / conversionCommon Stock 75,000 $0.99 $74,250.00
Disclosure

SEC source: 0001628280-23-042828 · wk-form4_1703803478.xml · nonDerivative · entry 1

Renz Justin A · CIK 0001466562 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 407,426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2023.

Read SEC document
December 18, 2023 Filed Dec 20, 2023 21:49 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 5,675 $6.07 $34,447.25
Disclosure

SEC source: 0001628280-23-042268 · wk-form4_1703108983.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 316,596

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.

Read SEC document
December 14, 2023 Filed Dec 15, 2023 23:13 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 7,000 $5.55 $38,850.00
Disclosure

SEC source: 0001628280-23-041699 · wk-form4_1702682026.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 322,271

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.

Read SEC document
December 11, 2023 Filed Dec 13, 2023 22:44 UTC SaleCommon Stock 50,000 $5.08 $253,925.00
Disclosure

SEC source: 0001628280-23-041479 · wk-form4_1702507443.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 275,675

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 24, 2023.

F2 · price: This transaction was executed in multiple trades in prices ranging from $4.99 to $5.27, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
December 08, 2023 Filed Dec 8, 2023 22:58 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 20,000 $5.27 $105,476.00
Disclosure

SEC source: 0001628280-23-041167 · wk-form4_1702076302.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 329,271

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.

F2 · price: This transaction was executed in multiple trades in prices ranging from $5.18 to $5.32, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
December 05, 2023 Filed Dec 6, 2023 21:49 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 10,272 $5.00 $51,360.00
Disclosure

SEC source: 0001628280-23-040906 · wk-form4_1701899354.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 349,271

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.

Read SEC document
November 30, 2023 Filed Dec 1, 2023 21:47 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 3,000 $4.50 $13,500.00
Disclosure

SEC source: 0001628280-23-040465 · wk-form4_1701467244.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 359,543

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 17:20 UTC
Rodriguez SusanChief Commercial Officer
SaleCommon Stock 4,714 $4.36 $20,563.41
Disclosure

SEC source: 0001628280-23-039904 · wk-form4_1700691637.xml · nonDerivative · entry 1

Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,973

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · balance_after: Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan in August 2023.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 22:22 UTC
Williams Laura AChief Medical Officer
SaleCommon Stock 2,581 $4.36 $11,258.84
Disclosure

SEC source: 0001628280-23-039907 · wk-form4_1700691709.xml · nonDerivative · entry 1

Williams Laura A · CIK 0001869194 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 266,191

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,933 shares under the Ardelyx Employee Stock Purchase Plan in August 2023.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 17:17 UTC
Blanks RobertSee Remarks
SaleCommon Stock 2,835 $4.36 $12,366.84
Disclosure

SEC source: 0001628280-23-039897 · wk-form4_1700691463.xml · nonDerivative · entry 1

Blanks Robert · CIK 0001815433 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,453

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 17:20 UTC
Renz Justin AChief Financial Officer
SaleCommon Stock 2,873 $4.36 $12,532.60
Disclosure

SEC source: 0001628280-23-039902 · wk-form4_1700691607.xml · nonDerivative · entry 1

Renz Justin A · CIK 0001466562 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 332,426

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,450 shares under the Ardelyx Employee Stock Purchase Plan in August 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.